Lilly Ledbetter never set out to be a trailblazer or a household name. She just wanted to be paid the same as a man for her ...

New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.

Britain on Monday asked its antitrust regulator to make growth and investment a priority as the government sought to woo some ...

Chief Executive David Ricks told then-UK Health Secretary Victoria Atkins last December that the company’s new Alzheimer’s ...

A summary of recent health news includes HIV transmission via organ transplants in Brazil, a reconsideration of Eli Lilly's ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

If you're looking for two magnificent growth stocks to start your long-term portfolio (or add to a portfolio) and have $500 ...

Eli Lilly and Company (NYSE:LLY – Get Free Report)’s stock price was up 1.1% during trading on Friday after Truist Financial raised their price target on the stock from $1,000.00 to $1,033.00. Truist ...

This summary provides the latest updates in health news, including HIV cases from organ transplants in Brazil, Sanofi's ...

Rep. Greg Landsman's recently disclosed stock trades have raised questions about when he knew about them and whether he ...

Read which pharmaceutical companies are addressing the risk of muscle mass loss associated with popular weight loss drugs from Novo (NOVO) and Eli Lilly (LLY).